Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
b-rayZ logo — Empower Mammography through Artificial Intelligence

b-rayZ

Empower Mammography through Artificial Intelligence

Founded 2019 Switzerland Schlieren, Switzerland 20 employees Series A Total: $4.16M AI, Analytics +1

General Information

Company Name b-rayZ
Founded Year 2019
Location Switzerland Schlieren, Switzerland
Employees 20
Industries AI, Analytics, Health Care
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with b-rayZ. To contact b-rayZ, visit b-rayz.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does b-rayZ compare?

A PDF of b-rayZ and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting b-rayZ soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About b-rayZ

is a health tech startup founded in 2019 and based in Switzerland. The company's slogan "Empower Mammography through Artificial Intelligence" encapsulates its mission to enhance mammography processes utilizing AI technology. As a spinoff of the University Hospital of Zurich, b-rayZ specializes in developing AI software that assists radiologists in mammography by offering real-time assessment of image quality and breast density. The key innovation offered by is its b-box, an AI-powered tool that enables real-time feedback on breast density and image quality. This addresses the challenge of early detection of breast cancer in patients with dense breast tissue and poor quality images. By leveraging AI algorithms, b-rayZ aims to streamline the assessment process, reducing costs and dependency on radiologists' visual inspections. The recent Fr.4.00M Series A investment in July 07, 2022 attracted notable investors including Eckenstein-Geigy Stiftung, Convergence Partners, LifeCare Partners, Protagon Group, showcasing confidence in the potential of b-rayZ's AI solutions for radiology. The company's focus on developing products that cater to the needs of radiologists aligns with the increasing demand for AI-driven advancements in the healthcare industry. Overall, presents a compelling proposition by effectively combining AI technology with mammography, aiming to enhance diagnostic accuracy, reduce costs, and optimize clinical workflow for radiologists. With its strong investor backing and clear vision for the future, b-rayZ holds significant promise in revolutionizing mammography practices through cutting-edge AI solutions.

Business keywords: Radiology, Mammography, Medical Imaging, AI Software, Breast Cancer Detection, University Hospital of Zurich, Image Analysis, Diagnostic Imaging, Clinical Decision Support, Radiologist Support, Innovation, Healthtech

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A B Fr.4.00M 5
Eckenstein-Geigy Stiftung Convergence Partners Swisspreneur
Eckenstein-Geigy Stiftung, Convergence Partners +3
07 Jul 2022
Grant B Fr.150.00K 1
InnoBooster
10 Jun 2021
Grant B Fr.10.00K 1
Venture Kick
Venture Kick
05 Feb 2019

b-rayZ Alternatives & Competitors

View All Alternatives
b-rayZ vs
MICA AI Medical
MICA AI Medical Israel

Mammography Image Comparison Analysis - Improving Early Detection Of Breast Cancer

Seed
9 employees
AI, Health Care
Compare b-rayZ vs MICA AI Medical
b-rayZ vs
CureMetrix
CureMetrix United States

CureMetrix supports the radiologist to improve mammography and save lives.

Series A
43 employees
AI, Biotechnology
Compare b-rayZ vs CureMetrix
b-rayZ vs
Therapixel
Therapixel France

Artificial Intelligence for efficient breast cancer screening

Series B
49 employees
AI, Health Care
Compare b-rayZ vs Therapixel
Also compare with: b-rayZ vs Vara Vara View all alternatives

FAQ About b-rayZ

Empower Mammography through Artificial Intelligence
b-rayZ was founded in 2019.
b-rayZ is headquartered in Schlieren, Switzerland.
b-rayZ operates in AI, Analytics and Health Care. Its work centres on Radiology, Mammography, Medical Imaging and AI Software.
b-rayZ has approximately 20 employees.
b-rayZ has completed 3 funding rounds, raising a total of $4.16M. The latest funding stage is Series A.
Top alternatives and competitors to b-rayZ include MICA AI Medical, CureMetrix, Therapixel, Hera-MI, Lunit Cancer Screening. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
b-rayZ and MICA AI Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for b-rayZ, https://bouncewatch.com/company/b-rayz, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes